Taisho Pharmaceutical Holdings Co (TSE:4581) Other Long Term Assets : 円192,129 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Taisho Pharmaceutical Holdings Co Other Long Term Assets?

Taisho Pharmaceutical Holdings Co's other long-term assets for the quarter that ended in Dec. 2023 was 円192,129 Mil.

Taisho Pharmaceutical Holdings Co's quarterly other long-term assets increased from Jun. 2023 (円179,687 Mil) to Sep. 2023 (円189,666 Mil) and increased from Sep. 2023 (円189,666 Mil) to Dec. 2023 (円192,129 Mil).

Taisho Pharmaceutical Holdings Co's annual other long-term assets declined from Mar. 2021 (円189,466 Mil) to Mar. 2022 (円176,945 Mil) but then increased from Mar. 2022 (円176,945 Mil) to Mar. 2023 (円185,948 Mil).

Taisho Pharmaceutical Holdings Co Other Long Term Assets Historical Data

The historical data trend for Taisho Pharmaceutical Holdings Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taisho Pharmaceutical Holdings Co Other Long Term Assets Chart

Taisho Pharmaceutical Holdings Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Long Term Assets

Get a 7-Day Free Trial

236,416.00

174,892.00

189,466.00

176,945.00

185,948.00

Taisho Pharmaceutical Holdings Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial															182,323.00	185,948.00	179,687.00	189,666.00	192,129.00

Taisho Pharmaceutical Holdings Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Taisho Pharmaceutical Holdings Co (TSE:4581) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taisho Pharmaceutical Holdings Co Ltd (TSE:4581) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

TAIPY:USA TAISF:USA

Address

3-24-1 Takada, Toshima-ku, Tokyo, JPN, 170-8655

Website

http://www.taisho-holdings.co.jp

Taisho Pharmaceutical Holding Co Ltd is a specialty and generic drug manufacturing company. The company maintains two operational segments, Self-Medication and Prescription Pharmaceuticals. The vast majority of Taisho's revenue is derived from its Self-Medication segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The vast majority of sales are generated by sales to external customers in Japan.

Taisho Pharmaceutical Holdings Co (TSE:4581) Headlines

No Headlines